CB Therapeutics, Inc.
11Patents
11Active
11Granted
51Portfolio score
Filing activity: Aug 1, 2013 → Jun 16, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10428146B2 | Anti PD-1 antibodies | Emerging Cross-Sectional Technologies | 8 | Active |
| US10435470B2 | Anti-PD-L1 antibodies | Chemistry; Metallurgy | 7 | Active |
| US11041002B1 | Malonate transporters | Chemistry; Metallurgy | 2 | Active |
| US10988785B1 | Isolated codon sequence | Chemistry; Metallurgy | 2 | Active |
| US10982243B2 | Methods for increasing production of cannabinoids in yeast cells | Chemistry; Metallurgy | 2 | Active |
| US11028417B1 | Isolated codon sequence | Chemistry; Metallurgy | 1 | Active |
| US11987602B2 | Malonate transporters | Chemistry; Metallurgy | 0 | Active |
| US9840477B2 | Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents | Chemistry; Metallurgy | 0 | Active |
| US10671632B1 | Automated pipeline | Physics | 0 | Active |
| US9695175B2 | Highly selective c-Met inhibitors as anticancer agents | Chemistry; Metallurgy | 0 | Active |
| US11441164B2 | Biosynthetic production of psilocybin and related intermediates in recombinant organisms | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.